Finch Therapeutics Group Inc (FNCH)
12.12
+0.17
(+1.45%)
USD |
OTCM |
Nov 05, 14:06
Finch Therapeutics Group Shareholders Equity (Quarterly): 14.22M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 14.22M |
| March 31, 2024 | 19.04M |
| December 31, 2023 | 22.89M |
| September 30, 2023 | 25.81M |
| June 30, 2023 | 27.89M |
| March 31, 2023 | 32.95M |
| December 31, 2022 | 95.71M |
| September 30, 2022 | 120.87M |
| Date | Value |
|---|---|
| June 30, 2022 | 159.09M |
| March 31, 2022 | 179.79M |
| December 31, 2021 | 202.22M |
| September 30, 2021 | 219.80M |
| June 30, 2021 | 228.19M |
| March 31, 2021 | 239.46M |
| December 31, 2020 | -95.72M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-95.72M
Minimum
Dec 2020
239.46M
Maximum
Mar 2021
99.48M
Average
95.71M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.58M |
| Total Liabilities (Quarterly) | 31.36M |